Article
Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer Cohort
6 May 2022
Abstract excerpt
Background The incidence and mortality rates of colon adenocarcinoma (COAD), which is the fourth most diagnosed cancer worldwide, are high. A subset of patients with COAD has shown promising responses to immunotherapy. However, the percentage of patients with COAD benefiting from immunotherapy is unclear. Therefore, gaining a better understanding of the immune milieu of colon cancer could aid in the development...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
